{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/2026117489",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1368305645"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#2026117489",
  "code": "XM9P29",
  "source": "http://id.who.int/icd/entity/2026117489",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Recombinant SARS-CoV-2 Vaccine (CHO Cell)"
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Recombinant SARS-CoV-2 Vaccine (CHO Cell)"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "National Vaccine and Serum Institute - Recombinant SARS-CoV-2"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Recombinant COVID-19 Vaccine (CHO cell, NVSI-06-08)"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Sinopharm CNBG COVID-19 vaccine"
      }
    }
  ]
}